Valuation (7%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.17 | 37.45 |
| PEG Ratio (TTM) | -0.01 | -7.22 |
| P/S Ratio (TTM) | 1.15 | 7.31 |
| P/B Ratio (TTM) | -0.64 | 1.41 |
| P/FCF Ratio (TTM) | -0.24 | 22.77 |
| Price to 5YR AVG Earnings Ratio | 0.00 | 125.78 |
| Price to 5YR AVG FCF Ratio | -0.19 | 92.76 |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -237.55% | 4.90% |
| ROE (TTM) | 205.97% | -3.51% |
| Net Profit Margin (TTM) | -559.52% | 11.70% |
| ROIC 5YR AVG | -287.13% | 11.15% |
Growth (48%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 24.68% | -1,770.12% | -1,037.14% |
| Revenue | 8.30% | 50.55% | 12.68% |
| Net Income | 5.74% | -3.35% | -1.51% |
| Cash Flow | 14.72% | 0.59% | -4.71% |
Health (7%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.40 | 1.56 |
| Quick Ratio (TTM) | 0.24 | 1.20 |
| D/E Ratio (TTM) | -1.17 | 0.21 |
| Interest Coverage (TTM) | -13.07 | 10.55 |
| Piotroski F-Score | 2 | 5 |
| Altman Z-Score | N/A | 12.52 |
| LTL to 5YR AVG FCF | -0.14 | 2.68 |
| Shares Outstanding Growth 5YR AVG | 1,035.53% | 1.16% |